In the latest trading session, Synopsys (SNPS) closed at $523.79, marking a +0.58% move from the previous day. The stock's change was more than the S&P 500's daily gain of 0.39%. At the same time, the ...

With the Medicare Annual Enrollment Period underway, many Ohioans find themselves weighing their health plan options for the ...

SNP Westminster leader Stephen Flynn told his colleague he planned to take her job just hours before announcing it to the ...

Virginians enrolled in both Medicare and Medicaid may be able to get expanded health benefits through what are known as ...

Fintel reports that on November 11, 2024, Loop Capital initiated coverage of Synopsys (NasdaqGS:SNPS) with a Buy ...

Being an affable sort of chiel who never bears grudges, I was happy to impart some advice to Stephen Flynn towards the end of last year when ...

AMSBIO’s CancerSeq™ FFPE tissues provide pre-screened tumour samples validated for single nucleotide polymorphisms (SNPs), ...

Long term Synopsys, Inc. (NASDAQ:SNPS) shareholders would be well aware of this, since the stock is up 285% in five years. But it's down 7.3% in the last week. But this could be related to the ...

Below is Validea's guru fundamental report for SYNOPSYS INC (SNPS). Of the 22 guru strategies we follow, SNPS rates highest using our P/B Growth Investor model based on the published strategy of ...

The general mood among these heavyweight investors is divided, with 25% leaning bullish and 37% bearish. Among these notable ...

Medicare Advantage Special Needs Plans now make up more than a quarter of all enrollments. Learn more about what they are and ...

Loop Capital Markets analyst Gary Mobley assigned a Buy rating to Synopsys (SNPS – Research Report) today and set a price target of $675.00. The company’s shares closed yesterday at $557.96. Mobley ...